Form 4: Amedisys Inc. Chief Legal Officer Reports Stock Transaction

Amedisys Inc.'s Chief Legal Officer, Jennifer G. Griffin, reported a transaction involving the withholding of 3,507 common stock shares to cover taxes upon the accelerated vesting of restricted stock units.

Summary

• Jennifer G. Griffin, Chief Legal Officer of Amedisys Inc., filed a Form 4 disclosing a transaction on December 27, 2024.
• The transaction involved the withholding of 3,507 shares of common stock at a price of $89.96 per share.
• This withholding was to cover taxes related to the accelerated vesting of restricted stock units (RSUs).
• The accelerated vesting was implemented to mitigate potential impacts under Sections 280G and 4999 of the Internal Revenue Code.
• Following the transaction, Ms. Griffin directly owns 14,000 shares of Amedisys common stock.
• She also indirectly owns 341 shares through a 401(k) plan, based on a statement dated September 30, 2024.

Sentiment

Score: 7

Explanation: The document is a routine disclosure of an insider transaction, which is neither positive nor negative. The accelerated vesting is a common practice, and the transaction itself is not indicative of any significant change in the company's outlook.

Industry Context

This filing is a routine disclosure of insider transactions, which is common for publicly traded companies. It provides transparency into the stock ownership of key executives.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, as mandated by the SEC.
• The transaction is typical for executives who receive stock-based compensation, such as RSUs.
• The accelerated vesting of RSUs to mitigate tax implications is a common strategy used by companies to manage executive compensation.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine disclosure of an executive's stock transaction.
• The accelerated vesting of RSUs may have a positive impact on the executive's compensation.

Key Dates

Keywords

Amedisys, stock transaction, Form 4, Jennifer G. Griffin, restricted stock units, RSUs, insider trading, executive compensation, tax withholding